World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
22364
World Ranking
2191
National Ranking
1062

Lisa H. Butterfield publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Lisa H. Butterfield sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 283 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Lisa H. Butterfield D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Lisa H. Butterfield sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Lisa H. Butterfield is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on immunotherapy, cancer immunology, and molecular biology, with significant contributions to oncology and microbiology.

The scientist has published extensively in the fields of medicine and immunology and microbiology, with particular attention to cancer research. Their subfields of study include:

  • Oncology
  • Immunology
  • Molecular Biology
  • Genetics
  • Cancer Research

The main topics of their work cover a range of areas in cancer immunotherapy and immune responses, specifically:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Glioma Diagnosis and Treatment
  • Cutaneous Melanoma Detection and Management
  • Immune cells in cancer
  • Pancreatic and Hepatic Oncology Research

Butterfield's frequent co-authors include:

  • John M. Kirkwood
  • Juraj Adamik
  • Samantha Bucktrout
  • Paul V. Munson
  • Walter J. Storkus

Their work has been published in a variety of scientific venues, with recurring publications in the following journals and conference proceedings:

  • Journal for ImmunoTherapy of Cancer
  • Regular and Young Investigator Award Abstracts
  • Journal of Translational Medicine
  • Nature Medicine
  • Cancer Immunology Research

Notable recent papers include:

  • "Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial," 2022, Nature Medicine
  • "Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations," 2023, Nature Reviews Immunology
  • "Hallmarks of Resistance to Immune-Checkpoint Inhibitors," 2022, Cancer Immunology Research
  • "Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma," 2020, Journal of Clinical Investigation
  • "Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells," 2022, Nature Communications

Best Publications

  • B cells and tertiary lymphoid structures promote immunotherapy response

    Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

  • Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

    Hideho Okada;Pawel Kalinski;Ryo Ueda;Aki Hoji

  • Immunotherapy of Cancer in 2012

    John M. Kirkwood;Lisa H. Butterfield;Ahmad A. Tarhini;Hassane Zarour

  • A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

    Lisa H. Butterfield;Antoni Ribas;Vivian B. Dissette;Yohan Lee

  • Current Developments in Cancer Vaccines and Cellular Immunotherapy

    Antoni Ribas;Lisa H. Butterfield;John A. Glaspy;James S. Economou

  • A comparison of gene transfer methods in human dendritic cells

    J F Arthur;L H Butterfield;M D Roth;L A Bui

  • Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

    F. Stephen Hodi;Sandra Lee;David F. McDermott;David F. McDermott;Uma N. Rao

  • Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

    Ahmad A. Tarhini;Howard D Edington;Lisa H. Butterfield;Yan Lin

  • Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma

    Lisa H. Butterfield;Antoni Ribas;Vivian B. Dissette;Saral N. Amarnani

  • T-cell responses to HLA-A*0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer

    Lisa H. Butterfield;Antoni Ribas;Wilson S. Meng;Vivian B. Dissette

  • Dendritic Cell-Based Cancer Vaccines.

    Patricia M. Santos;Lisa H. Butterfield

  • Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

    Ahmad A. Tarhini;Haris Zahoor;Yan Lin;Usha Malhotra

  • Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.

    Jun Zhou;Kathleen M. Mahoney;Kathleen M. Mahoney;Anita Giobbie-Hurder;Fengmin Zhao

  • Next Generation of Immunotherapy for Melanoma

    John M. Kirkwood;Ahmad A. Tarhini;Monica C. Panelli;Stergios J. Moschos

  • State of the Art Review: Cancer vaccines

    Lisa H Butterfield

  • Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

    Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

  • Generation of Human T-cell Responses to an HLA-A2.1-restricted Peptide Epitope Derived from α-Fetoprotein

    Lisa H. Butterfield;Andrew Koh;Wilson Meng;Charles M. Vollmer

  • Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

    Sacha Gnjatic;Vincenzo Bronte;Laura Rosa Brunet;Marcus O. Butler

  • Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas

    Ian F. Pollack;Regina I. Jakacki;Lisa H. Butterfield;Ronald L. Hamilton

  • Genetic Immunization for the Melanoma Antigen MART-1/Melan-A Using Recombinant Adenovirus-transduced Murine Dendritic Cells

    Antoni Ribas;Lisa H. Butterfield;William H. McBride;Syed M. Jilani

  • α-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma

    Charles M. Vollmer;Fritz C. Eilber;Lisa H. Butterfield;Antoni Ribas

Frequent Co-Authors

James S. Economou
James S. Economou University of California, Los Angeles
John M. Kirkwood
John M. Kirkwood University of Pittsburgh
Antoni Ribas
Antoni Ribas University of California, Los Angeles
Hideho Okada
Hideho Okada University of California, San Francisco
William H. McBride
William H. McBride University of California, Los Angeles
John A. Glaspy
John A. Glaspy University of California, Los Angeles
Ahmad A. Tarhini
Ahmad A. Tarhini Cleveland Clinic
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Francesco M. Marincola
Francesco M. Marincola National Institutes of Health
Pawel Kalinski
Pawel Kalinski Roswell Park Comprehensive Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Nursing, especially psychiatric nursing, offers varied roles supporting patient care and research.

Starting with foundational programs, students may find it easier to enter the field through the best easiest lpn programs to get into. Licensed Practical Nurse (LPN) programs provide essential clinical skills and serve as a stepping stone to advanced nursing education.

Advancing further, many aspire to become Nurse Practitioners. There are multiple options for the easiest NP programs to get into, which can allow quicker entry while maintaining quality education.

For those focused on mental health, the top psychiatric mental health nurse practitioner programs online offer excellent clinical placement support, critical for hands-on experience in this specialized field.

Budget-conscious students should also consider the cheapest psychiatric nurse practitioner programs, which provide accessible pathways without compromising educational value.

Best Scientists Citing Lisa H. Butterfield

Trending Scientists